CoFlo Medical
San Francisco, US · Founded 2022 · Delaware corporation
CoFlo Medical develops a drug-delivery platform based on core annular flow, which surrounds a viscous drug with a thin low-viscosity fluid so ultra-high-concentration biologics can be injected through fine needles at low force. Its CO-AXL hub adapts any primary container to enable at-home injection of highly viscous formulations (up to 400 mg/mL and over 1,000 cP), serving pharmaceutical developers and patients.
Founders & leadership
CoFlo Medical was founded in 2022 by Kripa Varanasi, Simon Rufer, and Vishnu Jayaprakash.



Board
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2025
▶$500KraisedNov 2025 · 1 investors · BiotechnologyRule 506(b)
- Matthew GoldmanDirector
- Kripa VaranasiDirector
- Simon RuferExecutive Officer, Director
- Vishnu JayaprakashExecutive Officer
- Offering amount
- $6M
- Amount sold
- $500K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with CoFlo Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does CoFlo Medical do?
- CoFlo Medical develops a drug-delivery platform based on core annular flow, which surrounds a viscous drug with a thin low-viscosity fluid so ultra-high-concentration biologics can be injected through fine needles at low force. Its CO-AXL hub adapts any primary container to enable at-home injection of highly viscous formulations (up to 400 mg/mL and over 1,000 cP), serving pharmaceutical developers and patients.
- Who founded CoFlo Medical?
- CoFlo Medical was founded by Kripa Varanasi, Simon Rufer, Vishnu Jayaprakash in 2022.
- How much funding has CoFlo Medical raised?
- CoFlo Medical has disclosed $500K raised across 1 round.
- Where is CoFlo Medical headquartered?
- CoFlo Medical is headquartered in San Francisco, US.